{"id":"f2d10c22-5d2a-5a74-994d-782ed0937e70","stable_key":"f812c44f-d0fd-5f01-ba2c-748c0794fcfb:coumarin-liver-toxicity","predicate":"associated_with","statement":"Serologic liver toxicity occurred in 6% of women during the coumarin trial.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"d4b28310-dfad-53ae-89e1-35f48d4ddc74","mechanism_event_label":"Liver injury signals appeared at this treatment exposure.","subject":{"id":"9fd9b93a-fdfd-5e09-92d3-0495bff41391","slug":"coumarin","display_name":"Coumarin","entity_type_key":"small_molecule"},"object":{"id":"60114f7e-e292-5498-8ae0-d33875c587ed","slug":"coumarin-human-liver-test-abnormalities","display_name":"Serologic liver toxicity during coumarin treatment","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"d4b28310-dfad-53ae-89e1-35f48d4ddc74","stable_key":"f812c44f-d0fd-5f01-ba2c-748c0794fcfb:coumarin-liver-toxicity-event","event_type":"observed_intervention","label":"Liver injury signals appeared at this treatment exposure.","description":"Serologic liver toxicity occurred in 6% of women during the coumarin trial.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"9fd9b93a-fdfd-5e09-92d3-0495bff41391","slug":"coumarin","display_name":"Coumarin","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"60114f7e-e292-5498-8ae0-d33875c587ed","slug":"coumarin-human-liver-test-abnormalities","display_name":"Serologic liver toxicity during coumarin treatment","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/coumarin-research/9929524.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"6d6d4760bdd321dda87f82927c5dfcc7120ed963c101d799473ed53ff4c7764b\", \"start_char\": 0, \"end_char\": 1579, \"text_sha256\": \"6d6d4760bdd321dda87f82927c5dfcc7120ed963c101d799473ed53ff4c7764b\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Randomized placebo-controlled crossover replication trial","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Coumarin 200 mg twice daily versus placebo, six months each","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Specific disease population and pharmacological exposure; liver-test incidence cannot be extrapolated to food doses.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Coumarin research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"coumarin","display_name":"Coumarin","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Liver injury signals appeared at this treatment exposure.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[coumarin-p9929524] Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. (1999). https://pubmed.ncbi.nlm.nih.gov/9929524/ DOI: 10.1056/nejm199902043400503","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"140 women with chronic arm lymphedema after breast cancer treatment","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"20298c81-3716-5e3b-8434-1e9f1efb58a7","evidence_kind":"source_excerpt","locator":"Lines 787-798","start_line":787,"end_line":798,"excerpt":"### coumarin-liver-toxicity\nSerologic liver toxicity occurred in 6% of women during the coumarin trial.\nCondition category: normal\nnutrient_topic: Coumarin research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Liver injury signals appeared at this treatment exposure.\norganism: Human\ntissue_or_cell_type: 140 women with chronic arm lymphedema after breast cancer treatment\nexperimental_model: Randomized placebo-controlled crossover replication trial\nlimitations: Specific disease population and pharmacological exposure; liver-test incidence cannot be extrapolated to food doses.\nexposure: Coumarin 200 mg twice daily versus placebo, six months each\nevidence_span: {\"source_cache\": \"artifacts/coumarin-research/9929524.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"6d6d4760bdd321dda87f82927c5dfcc7120ed963c101d799473ed53ff4c7764b\", \"start_char\": 0, \"end_char\": 1579, \"text_sha256\": \"6d6d4760bdd321dda87f82927c5dfcc7120ed963c101d799473ed53ff4c7764b\"}\n[coumarin-p9929524] Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. (1999). https://pubmed.ncbi.nlm.nih.gov/9929524/ DOI: 10.1056/nejm199902043400503","model_system":"Randomized placebo-controlled crossover replication trial","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [coumarin-p9929524] Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. (1999). https://pubmed.ncbi.nlm.nih.gov/9929524/ DOI: 10.1056/nejm199902043400503","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"30e0bbf1-757c-5baf-9102-e81bdd4382f0","stable_key":"import-f812c44f-d0fd-5f01-ba2c-748c0794fcfb","title":"Coumarin: metabolism, signaling and nutrient connections (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"069009019d00c903f4dc54e3793d189f4a61fb17b4803dbe73e73a677dfd0910","revision_id":"6596e0b7-7c3e-523a-a79a-aefb725d7d4c","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}